Avanos Medical, Inc. (NYSE: AVNS) reported Q4 EPS of $0.28, $0.06 better than the analyst estimate of $0.22. Revenue for the quarter came in at $185 million versus the consensus estimate of $184.15 million.

For earnings history and earnings-related data on Avanos Medical, Inc. (AVNS) click here.